Sol-Gel Technologies Ltd. SLGL
Annual
Quarterly
FY2025 · ended Dec 31, 2025 · Revenue $3.80M, -67.1% YoY · Filed Mar 19, 2026
Sol-Gel Technologies Ltd. (SLGL) files with the SEC under industry code 2834, Pharmaceutical Preparations. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $3.8 million and a net loss of $6.1 million. Free cash flow was $275,000. As of Dec 31, 2025 it held $24.0 million in cash and investments and $991,000 in total debt.
Revenue
$3.80M
-67.1% vs prior year
Net income
$-6.13M
+42.1% vs prior year
Operating cash flow
$322,000
+102.3% vs prior year
Free cash flow
$275,000
+102.0% vs prior year
EPS
$-2.19
+42.2% vs prior year
Dividend per share
None
Shares outstanding
2.79M
-90.0% vs prior year
Net cash
$23.01M
FY 2025
Operating margin
-198.4%
FY 2025
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SLGL (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Israel
- Headquarters
- Ness Ziona
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1684693
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $3.8M | $11.5M | $1.6M | $3.9M | $31.3M |
| Operating income | -$7.5M | -$12.0M | -$29.3M | -$16.2M | $3.0M |
| Net income | -$6.1M | -$10.6M | -$27.2M | -$14.9M | $3.2M |
| Diluted EPS | -$2.19 | -$3.79 | -$10.01 | -$0.65 | $0.14 |
| Operating cash flow | $322,000 | -$13.9M | -$17.7M | -$9.5M | -$7.7M |
| Free cash flow | $275,000 | -$13.9M | -$17.9M | -$9.7M | -$7.8M |
| Total assets | $29.9M | $35.8M | $45.3M | $46.6M | $69.2M |
| Total liabilities | $7.1M | $7.0M | $6.6M | $4.4M | $13.6M |
| Stockholders' equity | $22.8M | $28.9M | $38.6M | $42.2M | $55.6M |
| Cash and investments | $24.0M | $23.9M | $28.0M | $21.1M | $21.8M |
| Total debt | $991,000 | $1.3M | $1.7M | $772,000 | $1.6M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Oct 6, 2026 | Oct 6, 2026 |
| 6-K | Current report (foreign issuer) | Sep 30, 2026 | Sep 30, 2026 |
| 6-K | Current report (foreign issuer) | Sep 17, 2026 | Sep 17, 2026 |
| 6-K | Current report (foreign issuer) | Aug 20, 2026 | Jun 30, 2026 |
| 6-K | Current report (foreign issuer) | May 28, 2026 | May 28, 2026 |
| 6-K | Current report (foreign issuer) | Mar 24, 2026 | Mar 24, 2026 |
All 329 Sol-Gel Technologies Ltd. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.